________________________________________________________________________________________________________________________________

© B2Bioworld 2017 David DolingerOpening up Emerging Markets
for Rapid Diagnostics and Point-of-Care Assays

August 2017. The typical product development approach for rapid diagnotics will not satisfy business expectations: target industrialised countries first and cover R&D cost, launch it in low-income countries, and strip it to essential functions in order to offer a low-cost product.

David Dolinger is a veteran in the molecular diagnostics industry and NGO arena. He shares first-hand experience and insights with B2Bioworld’s readers and suggests a more promising approach to do business in emerging markets. What about human genetic diagnostics, or privacy? Which standards or regulations to follow? How matching design with pricing strategy?

Do’s and don’ts in designing technology platforms for diagnostics or developing point-of-care assays, and bringing these to low resource countries. Not just for medical purposes but including other applications such as in agriculture or food safety.

 

If you like to read this article, you can purchase it now

Please notice, If you order by email from an organisation - for-profit or nonprofit alike - you must buy an organisation sharing license and cannot buy an individual license. However the organisation sharing license entitles you to share the article with up to four other individuals - provided you adhere to the Terms and Conditions which you agree with when purchasing articles of B2Bioworld.

Read Now - Please select your license (Prices incl. 7% VAT)
12 pages free of advertisement

Article free of advertisement
- Includes added information on: Countries considered as "emerging markets"; Understandings of low/middle/high income economies; Results of tuberculosis tests (e.g. South Africa); Mobile laboratories BSL III; Compliance in tuberculosis treatment

Full Company License enquire here

Back to section

Related Editorial Articles

B2Bioworld offers you background information

Emerging Market Iran: How to shield your medical diagnostics assets

Roche Ethiopia: Build-up of an emerging market

The Laboratory Furniture Market
- Assessment and Outlook

We need the users, and users have to adopt it
A Global View on Interconnectivity, Quality, Harmonisation of Standards of Laboratory Automation and Biomanufacturing by Oscar-Werner Reif, Member of Board Sartorius Stedim Biotech S.A.

Pharma Boost for Red Cross/Red Crescent’s Community Disease Prevention Programme

Diagnostic Microfluidics: Sample In – Results Out?
Marc Feiglin, past Chief Technology Officer Life Sciences at Tecan on strengths and weaknesses of electrowetting development, weaknesses of competitors like Illumina. Prospects of clinical microfluidics

Eurofins helps Pasteur de Lille out of the doldrums

Seiko Epson and its Business Perspectives
Independent assessment. Includes an interview with Minoru Usui, CEO of the company

Emerging Market North Korea: Bringing medical diagnostics to an as yet closed off economy